The protective role of isorhamnetin on human brain microvascular endothelial cells from cytotoxicity induced by methylglyoxal and oxygen-glucose deprivation

被引:78
作者
Li, Wenlu [1 ,2 ]
Chen, Zhigang [1 ,3 ]
Yan, Min [1 ]
He, Ping [1 ]
Chen, Zhong [2 ]
Dai, Haibin [1 ,3 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmacol, Hangzhou 310058, Zhejiang, Peoples R China
[3] Zhejiang Univ, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Fas/FasL; isorhamnetin; methylglyoxal; oxygen-glucose deprivation; primary human brain microvascular endothelial cells; NF-KAPPA-B; DIABETIC-PATIENTS; DYSFUNCTION; ACTIVATION; QUERCETIN; RATS; HYPERGLYCEMIA; STROKE; STRESS; LIGAND;
D O I
10.1111/jnc.13436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
As the first target of stroke, cerebral endothelial cells play a key role in brain vascular repair and maintenance, and their function is impeded in diabetes. Methylglyoxal (MGO), a reactive dicarbonyl produced during glucose metabolism, accumulates in diabetic patients. MGO and MGO-induced advanced glycation end-products (AGEs) could ameliorate stroke-induced brain vascular damage, closely related with ECs dysfunction. Using MGO plus oxygen-glucose deprivation (OGD) to mimic diabetic stroke, we reported the protective effect of isorhamnetin on OGD induced cytotoxicity after MGO treatment on primary human brain microvascular endothelial cells (HBMEC) and explored the underlying mechanisms. Treatment of MGO for 24 h significantly enhanced 3-h OGD-induced HBMEC toxic effect, which was inhibited by pretreatment of isorhamnetin (100 mu mol/L). Moreover, the protective effect of isorhamnetin is multiple function dependent, which includes anti-inflammation, anti-oxidative stress and anti-apoptosis effects. Besides its well-known inhibition on the mitochondria-dependent or intrinsic apoptotic pathway, isorhamnetin also reduced activation of the extrinsic apoptotic pathway, as characterized by the decreased expression and activity of caspase 3 and caspase 8. Furthermore, pretreatment with isorhamnetin specifically inhibited FAS/FASL expression and suppressed nuclear factor-kappa B nuclear translocation. Taken together, our results indicated that isorhamnetin protected against OGD-induced cytotoxicity after MGO treatment in cultured HBMEC due to its multiple protective effects and could inhibit Fas-mediated extrinsic apoptosis. Therefore, isorhamnetin is a promising reagent for the treatment of hyperglycemia and ischemia-induced cerebral vascular degeneration.
引用
收藏
页码:651 / 659
页数:9
相关论文
共 39 条
[1]
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old [J].
Adams, Kenneth F. ;
Schatzkin, Arthur ;
Harris, Tamara B. ;
Kipnis, Victor ;
Mouw, Traci ;
Ballard-Barbash, Rachel ;
Hollenbeck, Albert ;
Leitzmann, Michael F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (08) :763-778
[2]
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content - Vascular endothelial growth factor decreases occludin in retinal endothelial cells [J].
Antonetti, DA ;
Barber, AJ ;
Khin, S ;
Lieth, E ;
Tarbell, JM ;
Gardner, TW .
DIABETES, 1998, 47 (12) :1953-1959
[3]
Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[4]
Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients - A systematic overview [J].
Capes, SE ;
Hunt, D ;
Malmberg, K ;
Pathak, P ;
Gerstein, HC .
STROKE, 2001, 32 (10) :2426-2432
[5]
Effect of cerivastatin on peripheral capillary permeability to albumin and peripheral nerve function in diabetic rats [J].
Cohen-Boulakia, F. E. ;
Tarhzaoui, K. ;
Valensi, P. E. ;
Lestrade, R. A. ;
Albertini, J. P. ;
Behar, A. .
DIABETES & METABOLISM, 2007, 33 (03) :189-196
[6]
Diabetic vascular complications [J].
Cooper, ME ;
Gilbert, RE ;
Jerums, G .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) :770-775
[7]
AMPK activation by isorhamnetin protects hepatocytes against oxidative stress and mitochondrial dysfunction [J].
Dong, Guang-Zhi ;
Lee, Ju-Hee ;
Ki, Sung Hwan ;
Yang, Ji Hye ;
Cho, Il Je ;
Kang, Seung Ho ;
Zhao, Rong Jie ;
Kim, Sang Chan ;
Kim, Young Woo .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 740 :634-640
[8]
Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats [J].
Duarte, J ;
Jiménez, R ;
O'Valle, F ;
Galisteo, M ;
Pérez-Palencia, R ;
Vargas, F ;
Pérez-Vizcaíno, F ;
Zarzuelo, A ;
Tamargo, J .
JOURNAL OF HYPERTENSION, 2002, 20 (09) :1843-1854
[9]
MECHANISMS OF DIABETIC COMPLICATIONS [J].
Forbes, Josephine M. ;
Cooper, Mark E. .
PHYSIOLOGICAL REVIEWS, 2013, 93 (01) :137-188
[10]
Effects of chronic quercetin treatment in experimental renovascular hypertension [J].
García-Saura, MF ;
Galisteo, M ;
Villar, IC ;
Bermejo, A ;
Zarzuelo, A ;
Vargas, F ;
Duarte, J .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 270 (1-2) :147-155